These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 30602322)
1. Pharmacotherapeutic options for co-morbid depression and alcohol dependence. Hillemacher T; Frieling H Expert Opin Pharmacother; 2019 Apr; 20(5):547-569. PubMed ID: 30602322 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment for dual diagnosis: a literature update and a proposal of intervention. Vitali M; Mistretta M; Alessandrini G; Coriale G; Romeo M; Attilia F; Rotondo C; Sorbo F; Pisciotta F; Attilia ML; Ceccanti M; Riv Psichiatr; 2018; 53(3):160-169. PubMed ID: 29912219 [TBL] [Abstract][Full Text] [Related]
3. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001 [TBL] [Abstract][Full Text] [Related]
4. Naltrexone and disulfiram in patients with alcohol dependence and current depression. Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B; J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239 [TBL] [Abstract][Full Text] [Related]
5. Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature. Snowden M; Sato K; Roy-Byrne P J Am Geriatr Soc; 2003 Sep; 51(9):1305-17. PubMed ID: 12919245 [TBL] [Abstract][Full Text] [Related]
6. Treatments for late-life bipolar disorder. Aziz R; Lorberg B; Tampi RR Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540 [TBL] [Abstract][Full Text] [Related]
7. Paradoxes of evidence in Russian addiction medicine. Mendelevich VD; Zalmunin KY Int J Risk Saf Med; 2015; 27 Suppl 1():S102-3. PubMed ID: 26639682 [TBL] [Abstract][Full Text] [Related]
8. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. Mercer D; Douglass AB; Links PS J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093 [TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217 [TBL] [Abstract][Full Text] [Related]
10. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727 [TBL] [Abstract][Full Text] [Related]
12. Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials. Kishi T; Sevy S; Chekuri R; Correll CU J Clin Psychiatry; 2013 Jul; 74(7):e642-54. PubMed ID: 23945459 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of alcoholism - an update on approved and off-label medications. Soyka M; Müller CA Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Torrens M; Fonseca F; Mateu G; Farré M Drug Alcohol Depend; 2005 Apr; 78(1):1-22. PubMed ID: 15769553 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of depression complicated by abuse and dependence on alcohol]. Ivanets NN; Lavrinenko OV; Maximova TN Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):53-58. PubMed ID: 28805761 [TBL] [Abstract][Full Text] [Related]
16. Current and potential pharmacological treatment options for insomnia in patients with alcohol use disorder in recovery. Roehrs TA; Auciello J; Tseng J; Whiteside G Neuropsychopharmacol Rep; 2020 Sep; 40(3):211-223. PubMed ID: 32543111 [TBL] [Abstract][Full Text] [Related]
17. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028 [TBL] [Abstract][Full Text] [Related]
18. An open-label pilot study of icariin for co-morbid bipolar and alcohol use disorder. Xiao H; Wignall N; Brown ES Am J Drug Alcohol Abuse; 2016 Mar; 42(2):162-7. PubMed ID: 26809351 [TBL] [Abstract][Full Text] [Related]
19. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818 [TBL] [Abstract][Full Text] [Related]